ArticleInternational journal of cancer2023

Phase 1 trial of CV301 in combination with anti-PD-1 therapy in nonsquamous non-small cell lung cancer.

Arun Rajan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.